XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
Cassidy J; Tabernero J; Twelves C; Brunet R; Butts C; Conroy T; Debraud F; Figer A; Grossmann J; Sawada N; Schöffski P; Sobrero A; Van Cutsem E; Díaz-Rubio E; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2004, vol. 22, issue 11, p 2084, ISSN 0732183x. ISBN 0732183x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef